Mosaic Laboratories, L.L.C.

Mosaic Laboratories, L. L. C. is a Contract Research Organization (CRO) focused on precision medicine and drug development, offering advanced services in bioinformatics, biostatistics, and integrated sample management.

Founded in 2005 in Lake Forest, US, Mosaic Laboratories specializes in providing various research solutions. In January 2021, it became a subsidiary of HistoGeneX N. V. / Caprion Biosciences Inc.

, following its acquisition by Arsenal Capital Partners. The company has engaged in one notable deal since its inception, indicating a focused operational strategy. Mosaic Laboratories operates as a global CRO, delivering precision medicine and drug development solutions. Its extensive offerings include bioinformatics, biostatistics, integrated sample management, and logistics tailored for complex therapeutic areas, particularly oncology.

The company employs innovative technologies for comprehensive testing solutions, serving diverse clients from biopharmaceuticals to academic institutions across North America, Europe, and Asia. Revenue for Mosaic Laboratories is generated through service contracts with clients, primarily biopharmaceutical companies and research institutions. Their B2B model includes tailored agreements for biomarker analysis and genomic testing. Specific pricing remains proprietary, reflecting the complexity of their services and the long-term partnerships pursued with clients.

As of January 2021, following its acquisition, Mosaic Laboratories is expected to leverage new opportunities under HistoGeneX N. V. / Caprion Biosciences Inc. plans for future growth include enhancing its service portfolio and potentially expanding into new geographic markets.

The company aims to utilize resources from the acquisition to support the development and launch of innovative products, aligning with the strategic focus of its new parent company.